Literature DB >> 19025364

The many faces of Pseudomonas aeruginosa in chronic obstructive pulmonary disease.

Timothy F Murphy1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 19025364     DOI： 10.1086/593187

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  12 in total

1.  Inhibiting the BfrB:Bfd interaction in Pseudomonas aeruginosa causes irreversible iron accumulation in bacterioferritin and iron deficiency in the bacterial cytosol.

Authors:  Kate Eshelman; Huili Yao; Achala N D Punchi Hewage; Jacqueline J Deay; Josephine R Chandler; Mario Rivera
Journal:  Metallomics       Date:  2017-06-21       Impact factor: 4.526

Review 2.  Pyocyanin effects on respiratory epithelium: relevance in Pseudomonas aeruginosa airway infections.

Authors:  Balázs Rada; Thomas L Leto
Journal:  Trends Microbiol       Date:  2012-11-07       Impact factor: 17.079

3.  An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections.

Authors:  Martina Koeva; Alina D Gutu; Wesley Hebert; Jeffrey D Wager; Lael M Yonker; George A O'Toole; Frederick M Ausubel; Samuel M Moskowitz; Diane Joseph-McCarthy
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

4.  Express Yourself: Quantitative Real-Time PCR Assays for Rapid Chromosomal Antimicrobial Resistance Detection in Pseudomonas aeruginosa.

Authors:  Derek S Sarovich; Erin P Price; Danielle E Madden; Olusola Olagoke; Timothy Baird; Jane Neill; Kay A Ramsay; Tamieka A Fraser; Scott C Bell
Journal:  Antimicrob Agents Chemother       Date:  2022-04-25       Impact factor: 5.938

5.  An epoxide hydrolase secreted by Pseudomonas aeruginosa decreases mucociliary transport and hinders bacterial clearance from the lung.

Authors:  Kelli L Hvorecny; Emily Dolben; Sophie Moreau-Marquis; Thomas H Hampton; Tamer B Shabaneh; Becca A Flitter; Christopher D Bahl; Jennifer M Bomberger; Bruce D Levy; Bruce A Stanton; Deborah A Hogan; Dean R Madden
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-10-05       Impact factor: 5.464

6.  Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa.

Authors:  L Millares; R Ferrari; M Gallego; M Garcia-Nuñez; V Pérez-Brocal; M Espasa; X Pomares; C Monton; A Moya; E Monsó
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-22       Impact factor: 3.267

7.  Transcriptionally Active Lung Microbiome and Its Association with Bacterial Biomass and Host Inflammatory Status.

Authors:  Lili Ren; Rongbao Zhang; Jian Rao; Yan Xiao; Zhao Zhang; Bin Yang; Depan Cao; Hui Zhong; Pu Ning; Ying Shang; Mingkun Li; Zhancheng Gao; Jianwei Wang
Journal:  mSystems       Date:  2018-10-30       Impact factor: 6.496

8.  Pseudomonas aeruginosa infection increases the readmission rate of COPD patients.

Authors:  Juwhan Choi; Jee Youn Oh; Young Seok Lee; Gyu Young Hur; Sung Yong Lee; Jae Jeong Shim; Kyung Ho Kang; Kyung Hoon Min
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-02

9.  Does a single Pseudomonas aeruginosa isolation predict COPD mortality?

Authors:  Afroditi K Boutou; Yogini Raste; Jeremy Reid; Khalid Alshafi; Michael I Polkey; Nicholas S Hopkinson
Journal:  Eur Respir J       Date:  2014-07-17       Impact factor: 16.671

10.  The Human Virome Protein Cluster Database (HVPC): A Human Viral Metagenomic Database for Diversity and Function Annotation.

Authors:  Ali H A Elbehery; Judith Feichtmayer; Dave Singh; Christian Griebler; Li Deng
Journal:  Front Microbiol       Date:  2018-05-29       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.